A total of 14 million doses of Bulk Ready to Fill (RTF) Covid-19 vaccines arrived at Bio Farma (30/6). With the arrival of the 18th stage of the vaccine, so far Indonesia has received 118.7 million doses of vaccine, consisting of 13.2 million doses of vaccine produced by Sinovac, AstraZeneca, and Sinopharm. Then 105.5 million doses of Sinovac vaccine produced in the form of raw materials. (Photo: Andzar / Corcom Bio Farma)
(Bandung 30/6) Bio Farma continues to meet the demand for the Covid-19 vaccine to be used by the public. Bio Farma's readiness can be seen from the continuous process of filling and finishing the Covid-19 vaccine at Bio Farma's production facilities. As of June 30, 2021, 69.1 million doses of the Covid-19 vaccine have been produced at Bio Farma, of which 57.9 million have received lot releases from the POM, and the remaining 11.1 million doses are still waiting for the lot release from the POM. POM Agency. This number will continue to grow until it reaches 85 million doses after the return of the Covid-19 vaccine raw materials from Sinovac as many as 14 million doses on June 30, 2021.
With the arrival of the 18th stage of the vaccine, so far Indonesia has received 118.7 million doses of vaccine, consisting of 13.2 million doses of vaccine produced by Sinovac, AstraZeneca, and Sinopharm. Then 105.5 million doses of vaccine produced by Sinovac are in the form of raw materials, which after processing at Bio Farma, 85 million vaccines will be produced in finished form. So that in total from various brands, as of June 30, Indonesia has as many as 98.2 million doses of ready-made vaccines. This was conveyed by the Indonesian Minister of Health, Budi G Sadikin in welcoming the arrival of the 18th batch of vaccines / vaccine raw materials on June 30, 2021.
"So the total vaccine raw materials from Sinovac that have come to us are 105 million doses of vaccine. And it takes about a month at Bio Farma to process it into a ready-to-use vaccine, from 105 million it will turn into 85 million vaccines,” said Budi G Sadikin. The Minister of Health reminded that this vaccine does not make it immune to the COVID-19 virus. However, this vaccine makes the body more resistant, indicates if exposed to the virus more quickly, and responds faster against the virus.
"For this reason, even though you have been vaccinated, you must continue to carry out health protocols, first wear a mask, keep your distance and wash your hands," Said Budi.
In the near future, Indonesia will also receive additional vaccine supplies from the AstraZeneca COVAX Facility, which is a grant from Japan, which is expected to arrive in Indonesia in July 2021.
In terms of distribution, as of June 30, 2021, Bio Farma has distributed as of June 30, 2021, as many as 63.9 million doses consisting of 8.2 million doses of AstraZeneca, 3 million doses of CoronaVac and 52.7 million doses of the Covid-19 Vaccine. (ed/ss)